[go: up one dir, main page]

DK1761779T3 - Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem - Google Patents

Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem

Info

Publication number
DK1761779T3
DK1761779T3 DK04764118T DK04764118T DK1761779T3 DK 1761779 T3 DK1761779 T3 DK 1761779T3 DK 04764118 T DK04764118 T DK 04764118T DK 04764118 T DK04764118 T DK 04764118T DK 1761779 T3 DK1761779 T3 DK 1761779T3
Authority
DK
Denmark
Prior art keywords
colorectal
transthyretin
colorectal adenoma
biomarker
adenoma
Prior art date
Application number
DK04764118T
Other languages
Danish (da)
English (en)
Inventor
Hartmut Juhl
Kerstin David
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1761779(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Application granted granted Critical
Publication of DK1761779T3 publication Critical patent/DK1761779T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
DK04764118T 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem DK1761779T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (fr) 2004-08-13 2004-08-13 Utilisation de transthyretine en tant que biomarqueur de l'adenome et/ou du carcinome colorectal ; procede de detection et systeme de test

Publications (1)

Publication Number Publication Date
DK1761779T3 true DK1761779T3 (da) 2008-02-25

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04764118T DK1761779T3 (da) 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem
DK05772471T DK1776587T3 (da) 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK05772471T DK1776587T3 (da) 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Country Status (20)

Country Link
US (2) US7951528B2 (fr)
EP (3) EP1843159A1 (fr)
JP (2) JP4916441B2 (fr)
KR (1) KR20070051328A (fr)
CN (2) CN101014859A (fr)
AT (2) ATE376674T1 (fr)
AU (2) AU2004322162B2 (fr)
BR (1) BRPI0419002A (fr)
CA (2) CA2577601A1 (fr)
DE (2) DE602004009716T2 (fr)
DK (2) DK1761779T3 (fr)
ES (2) ES2295907T3 (fr)
IL (2) IL181131A (fr)
MX (2) MX2007001479A (fr)
NO (2) NO20070599L (fr)
PL (2) PL1761779T3 (fr)
PT (2) PT1761779E (fr)
SI (1) SI1776587T1 (fr)
WO (2) WO2006015616A1 (fr)
ZA (1) ZA200701188B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004009716T2 (de) 2004-08-13 2008-08-28 Indivumed Gmbh Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
EP1775590A1 (fr) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Procédé non invasif pour la détection in vitro du carcinome transitionnel de la vessie
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2009025080A1 (fr) * 2007-08-18 2009-02-26 School Juridical Person Kitasato Institute Polypeptide marqueur du cancer colorectal et procédé de diagnostic du cancer colorectal
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
KR20150090240A (ko) * 2012-11-30 2015-08-05 어플라이드 프로테오믹스, 인크. 결장 종양의 존재 또는 위험의 평가 방법
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
AU2015237229A1 (en) * 2014-03-28 2016-11-10 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
ES2813829T3 (es) * 2014-08-22 2021-03-25 Abbott Lab Métodos para la detección temprana del cáncer colorrectal
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
GB2545361B (en) 2015-04-10 2018-01-24 Applied Proteomics Inc Methods of assessing colorectal cancer status
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
EP4179111B1 (fr) 2020-07-10 2024-04-03 Guardant Health, Inc. Procédés de détection de réarrangements génomiques à l'aide d'acides nucléiques acellulaires
WO2023282916A1 (fr) 2021-07-09 2023-01-12 Guardant Health, Inc. Procédés de détection de réarrangements génomiques à l'aide d'acides nucléiques acellulaires
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
WO2002059621A2 (fr) 2001-01-24 2002-08-01 Bayer Corporation Regulation de transthyretine afin de traiter l'obesite
AU2002316299A1 (en) 2001-06-22 2003-01-08 Merck And Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
WO2004001072A2 (fr) 2002-06-19 2003-12-31 Oncotherapy Science, Inc. Procede permettant de diagnostiquer des tumeurs colo-rectales
EP1540010B8 (fr) 2002-08-06 2010-07-14 The Johns Hopkins University Utilisation de biomarqueurs pour detecter un cancer de l'ovaire
CA2526878A1 (fr) * 2003-04-08 2004-10-21 Colotech A/S Procede de detection d'un cancer colorectal dans des echantillons humains
WO2005008251A2 (fr) 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, trousses et methodes d'identification, d'evaluation, de prevention et de traitement de l'endometriose
DE602004009716T2 (de) 2004-08-13 2008-08-28 Indivumed Gmbh Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
MX2007001770A (es) 2004-08-13 2007-08-07 Egomedical Technologies Ag Sistema de prueba de analitos para determinar la concentracion de un analito en un fluido fisiologico o acuoso.
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
NO20070599L (no) 2007-05-14
CN101014859A (zh) 2007-08-08
BRPI0419002A (pt) 2007-12-11
MX2007001479A (es) 2007-07-25
EP1761779B1 (fr) 2007-10-24
AU2004322162A1 (en) 2006-02-16
EP1776587A1 (fr) 2007-04-25
MX2007001254A (es) 2007-10-05
AU2004322162A2 (en) 2006-02-16
AU2004322162B2 (en) 2011-04-28
IL181132A0 (en) 2007-07-04
DE602004009716D1 (de) 2007-12-06
WO2006053592A1 (fr) 2006-05-26
EP1776587B1 (fr) 2008-12-31
ATE376674T1 (de) 2007-11-15
DE602004009716T2 (de) 2008-08-28
JP4916441B2 (ja) 2012-04-11
JP2008509409A (ja) 2008-03-27
KR20070051328A (ko) 2007-05-17
EP1776587B9 (fr) 2009-09-16
IL181132A (en) 2011-04-28
ES2322378T3 (es) 2009-06-19
US20080160515A1 (en) 2008-07-03
EP1761779A1 (fr) 2007-03-14
PL1761779T3 (pl) 2008-04-30
JP4592753B2 (ja) 2010-12-08
CA2577601A1 (fr) 2006-02-16
WO2006015616A1 (fr) 2006-02-16
US7883842B2 (en) 2011-02-08
PL1776587T3 (pl) 2009-06-30
CA2576998A1 (fr) 2006-05-26
IL181131A0 (en) 2007-07-04
PT1761779E (pt) 2008-02-01
EP1843159A1 (fr) 2007-10-10
JP2008509407A (ja) 2008-03-27
PT1776587E (pt) 2009-04-03
SI1776587T1 (sl) 2009-06-30
ZA200701188B (en) 2009-01-28
ES2295907T3 (es) 2008-04-16
US7951528B2 (en) 2011-05-31
NO20070598L (no) 2007-05-14
ATE419534T1 (de) 2009-01-15
IL181131A (en) 2011-03-31
DE602005012108D1 (de) 2009-02-12
AU2005306103A1 (en) 2006-05-26
CN101014861A (zh) 2007-08-08
US20070184499A1 (en) 2007-08-09
DK1776587T3 (da) 2009-04-20

Similar Documents

Publication Publication Date Title
IL181132A0 (en) Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2008095152A3 (fr) Procédés et substances permettant d'identifier l'origine d'un carcinome d'origine principale inconnue
WO2007035690A3 (fr) Methodes de diagnostic du cancer du pancreas
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
RU2018124339A (ru) Способ и система для сенсорного обнаружения посредством модифицированной наноструктуры
GB2427468B (en) Cell separation device and method for the detection of EpCAM positive cells
WO2008134526A3 (fr) Profilage de glycoprotéines du cancer de la vessie
WO2006023769A3 (fr) Determination de qualite de donnees et/ou d'aneusomie segmentaire l'aide d'un systeme informatique
WO2009058902A3 (fr) Procédés et dispositifs pour une détection d'analyte
WO2005041893A3 (fr) Detection des biomarqueurs de l'infarctus aigu du myocarde
JP2015514987A5 (fr)
WO2008109075A3 (fr) Biomarqueurs et procédés pour déterminer une sensibilité à des antagonistes de ctla-4
MX2021008520A (es) Metodos y sistemas para deteccion de analitos.
CA2701341A1 (fr) Procede de detection du cancer colorectal a partir d'un echantillon de selles au moyen d'une combinaison de marqueurs associant la calprotectine et le complexe hemoglobine/haptoglobine
WO2010009074A3 (fr) Procédé de prédiction et de détection de métastases tumorales
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2007005666A3 (fr) Systeme et methode de detection d'analytes au moyen de recepteurs differentiels
WO2015077382A3 (fr) Test cytologique et moléculaire combiné pour la détection précoce d'adénocarcinome œsophagien
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2009063249A3 (fr) Détection précoce de sepsie
WO2014044791A3 (fr) Procédés et trousses pour la prédiction de la sensibilité d'un sujet vis-à-vis d'une chimiothérapie
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
DK2027750T3 (da) Fremgangsmåde og system til detektion af akustisk chok og anvendelse af denne fremgangsmåde i høreapparater
FI20011908A0 (fi) Menetelmä vatsasyövän osoittamiseksi
WO2004097030A3 (fr) Biomarqueurs pronostiques du cancer du sein